Trump’s Health Policy Agenda: Proposed Changes to Abortion, Transgender Rights, and Medicare

Overview of Trump’s Health Policies

This document outlines potential health policies under Donald Trump’s leadership as described in his Agenda 47 and Project 2025. The policies suggest significant changes in areas including abortion, transgender rights, Medicare for seniors, and pharmaceutical accountability.

Abortion Policies

1. Ban on Abortion Pills: The Trump administration aims to ban late-term abortions and restrict the availability of abortion pills.
2. Restrictions on Research: Project 2025 proposes that embryonic stem cell research be prohibited and that the CDC stops promoting abortion as health care.
3. Reporting of Abortions: It calls for accurate reporting on abortion statistics, targeting states known as “sanctuaries for abortion tourism.”
4. Funding Cuts: Planned Parenthood will not receive Medicaid funding, with the claim that abortion is not part of health care.

Policies on Transgender Rights

1. Participation in Sports: Trump pledges to keep transgender women out of women’s sports.
2. Medical Treatment Restrictions: The agenda includes stopping taxpayer funding for sex change surgeries and restricting schools from discussing gender identity without parental consent.
3. Gender Recognition: Trump wants Congress to pass a bill recognizing only two genders: male and female.

Medicare Changes for Seniors

1. No Cuts to Medicare: Trump claims he will not cut Medicare funding but may restructure it, making Medicare Advantage the default plan.
2. Increased Costs: Critics warn that these changes may lead to higher expenses for beneficiaries.
3. Support for Seniors: The plan includes increased focus on chronic disease prevention and at-home care support for seniors.

Pharmaceutical Accountability

1. Ending Drug Shortages: Trump aims to halt pharmaceutical shortages and bring production of essential medicines back to the U.S.
2. Accountability for “Big Pharma”: He seeks to hold the pharmaceutical industry accountable for childhood illnesses and drug addiction.
3. Lowering Drug Costs: Project 2025 proposes preventing pharmaceutical companies from delaying the entry of generic drugs into the market.

These proposed policies reflect a conservative shift in health care, affecting access to reproductive health, transgender rights, senior care, and accountability for drug companies.